Patient characteristics and treatment patterns in resectable early-stage NSCLC: UK subgroup analysis of a global real-world study

被引：0

作者：

Escriu, Carles ^{[1
]}

Rathinam, Sridhar ^{[2
]}

Kahangire, Doreen ^{[3
]}

Nagar, Saurabh ^{[4
]}

Davis, Keith ^{[4
]}

Jimenez, Maria ^{[4
]}

Sandelin, Martin ^{[5
]}

Chow, Jason ^{[6
]}

机构：

[1] Clatterbridge Canc Ctr, Liverpool, Merseyside, England

[2] Glenfield Hosp, Leicester, Leics, England

[3] AstraZeneca, Oncol Business Unit, Med Affairs, Cambridge, England

[4] RTI Hlth Solut, Res Triangle Pk, NC USA

[5] AstraZeneca, Oncol Business Unit, Sodertalje, Sweden

[6] St Georges Univ Hosp NHS Fdn Trust, London, England

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S17 / S17

页数：1